Your company, which is financed entirely with common equity, plans to manufacture a new product, a cell phone that can be worn like a wristwatch. Two robotic machines are available to make the phone, Machine A and Machine B. The price per phone will be $260.00 regardless of which machine is used to make it. The fixed and variable costs associated with the two machines are shown below, along with the capital (all equity) that must be invested to purchase each machine. The expected sales level is 27,000 units. Your company has tax loss carry-forwards that will cause its tax rate to be zero for the life of the project, so T = 0. How much higher or lower will the project's ROE be if you select the machine that produces the higher ROE, i.e., what is ROEB - ROEA? (Hint: Since the firm uses no debt and its tax rate is zero, ROE = EBIT/Required investment.)
| Machine A | Machine B | |
| Price per phone (P) | $260.00 | $260.00 |
| Fixed costs (F) | $1,000,000 | $2,000,000 |
| Variable cost/unit (V) | $210.00 | $160.00 |
| Expected unit sales (Q) | 27,000 | 27,000 |
| Required equity investment | $2,500,000 | $3,000,000 |
|
|||
|
|||
|
|||
|
|||
|
| Machine A | Machine B | |
| Price per phone (P) | $260.00 | $260.00 |
| Fixed costs (F) | $1,000,000 | $2,000,000 |
| Variable cost/unit (V) | $210.00 | $160.00 |
| Expected unit sales (Q) | 27,000 | 27,000 |
| Required equity investment | $2,500,000 | $3,000,000 |
| EBIT | $350,000.00 | $700,000.00 |
| ROE | 14.00% | 23.33% |
| Difference in ROE | 9.33% | |
| Hence, the answer is c.9.33% |

Your company, which is financed entirely with common equity, plans to manufacture a new product, a...
15. Your company plans to produce a new product, a wireless computer mouse. Two machianhine i mouse, Machines A and B. The price per mouse will be $25.00 regardless of wh can be used to make the variable costs associated with the two machines are shown below. At the expecteda which machine is used. The fixed and much higher or lower will the firm's expected EBIT be if it uses Machine B rather than Machine A, ie., what is EBITB...
NexxGen is a Pharmaceutical Company which is considering investing in a new production line of portable electrocardiogram (ECG) machines for its clients who suffer from cardiovascular diseases. The company has to invest in equipment which costs $2,500,000 and falls within a MARCS depreciation of 5 years, and is expected to have a scrap value of $200,000 at the end of the project. Other than the equipment, the company needs to increase its cash and cash equivalents by $100,000, increase the...